Technical analysis of Marsh & McLennan Companies, Inc. (MRSH): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals. This entity serves as the parent company for several prominent advisory and consulting brands.
Price Performance
| 1 month | +17.97% |
| 3 months | +4.79% |
| Year-to-date | +8.14% |
| 1 year | +12.61% |
| 3 years | +3.45% |
| 5 years | +23.37% |
| 10 years | +213.96% |
52-Week Range
| 52-week High | $202.70 |
| 52-week Low | $156.60 |
| Avg Volume (90d) | 2.5M |
Technical Indicators
| SMA 50 | $182.35 |
| SMA 200 | $177.17 |
| Beta | 0.75 |
| 30-day Volatility (annualised) | 24.0% |
| Price vs SMA 50 | +10.0% |
| Price vs SMA 200 | +13.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $185.52 | |
| 2026-01 | $188.19 | +1.4% |
| 2026-02 | $186.74 | -0.8% |
| 2026-03 | $173.45 | -7.1% |
| 2026-04 | $167.71 | -3.3% |
| 2026-05 | $159.97 | -4.6% |
| 2026-06 | $166.67 | +4.2% |
| 2026-07 | $189.69 | +13.8% |
| 2026-08 | $189.80 | +0.1% |
| 2026-09 | $170.73 | -10.0% |
| 2026-10 | $200.62 | +17.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-04 | $2.20 | $6.91B |
| 2026-10-15 | $1.97 | $6.64B |
| 2026-07-21 | $2.90 | $7.28B |
| 2026-04-16 | $3.22 | $7.41B |
| 2026-01-29 | $1.97 | $6.56B |
| 2025-10-16 | $1.78 | $6.32B |
| 2025-07-17 | $2.67 | $6.94B |
Price
| Price | $205.38 (closing price, November 2, 2026) |
| Market Cap | $98.0B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 24.57 |
| Price / Book | 6.66 |
| Dividend Yield | 1.84% |
Financial Health
| Debt / Equity | 1.52 |
| Current Ratio | 1.09 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 2.76 |